Selling your home is often a long and confusing process, especially if you've never done it before. And while homebuyers are ...

U.S. consumers spent slightly more at retail stores last month after ramping up their shopping in March to get ahead of tariffs ...

This article will provide an overview of the current state of hemp and CBD regulation, explore the growing popularity of hemp ...

ACHIEVED ANOTHER RECORD IN QUARTERLY REVENUES OF $62 MILLION AND ADJUSTED EBITDA OF $22 MILLION. (All amounts in U.S. dollars unless otherwise ...

policies and applications don't change for the balance of the quarter," Apple expects a $900 million increase in costs. Cook said the majority of iPhones sold in the US will eventually be made in ...

The Belo family-led company disclosed to the stock exchange on Monday its net sales inched up by 1.2 percent ... in-house brand categories. Operating costs were up by 7.8 percent to P2.66 billion ...

It also flagged a total cost impact of up to $35 million on its operating earnings for the next fiscal year. The firm's downbeat guidance joins a growing list of big-cap companies which are either ...

By layering incrementality testing into your cost analysis, you gain a KPI that tells you not just what you paid for a lead or sale, but what you paid for an actual new customer. It’s where the ...

Swedish car giant Volvo has announced it will embark on a £1.4billion cost-saving drive to 'offset external headwinds', which includes a decline in electric vehicle sales. Among the cost-cutting ...

US drugmaker Pfizer reported first-quarter profit above Wall Street estimates on Tuesday, helped by cots cuts and better-than-expected sales of its heart disease drug, Vyndaqel. On an adjusted basis, ...

Instead of owning its policy, the White House has bullied Amazon to keep quiet about what it will cost. The spat started Tuesday morning when Punchbowl News reported that Amazon planned to show ...

Pfizer on Tuesday expanded its cost-cutting efforts and reported first-quarter profit that topped estimates, even as the company's sales fell, largely due to dwindling revenue for its antiviral ...